Larimar Therapeutics (LRMR) PT Lowered to $18 at Citizens JMP
Tweet Send to a Friend
Citizens JMP analyst Jonathan Wolleben lowered the price target on Larimar Therapeutics (NASDAQ: LRMR) to $18.00 (from $22.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
